SCHEMBL26260045

SCHEMBL26260045

COc1ccc2c(-c3ccsc3)c(OC)cc(-c3ccsc3)c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 2/20 0.46
▸ MAOA P21397 1/20 0.46
▸ SIK1 P57059 1/20 0.45
▸ SIK2 Q9H0K1 1/20 0.45
▸ SIK3 Q9Y2K2 1/20 0.45
▸ PDGFRB P09619 4/20 0.44
▸ PDGFRA P16234 4/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ TUBB4A P04350 3/20 0.40
▸ TUBB P07437 3/20 0.40
▸ TUBA3C P0DPH7 3/20 0.40
▸ TUBA1B P68363 3/20 0.40
▸ TUBA4A P68366 3/20 0.40
▸ TUBB4B P68371 3/20 0.40
▸ TUBB3 Q13509 3/20 0.40
▸ TUBB2A Q13885 3/20 0.40
▸ TUBB8 Q3ZCM7 3/20 0.40
▸ TUBA3E Q6PEY2 3/20 0.40
▸ TUBA1A Q71U36 3/20 0.40
▸ TUBA1C Q9BQE3 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8503242 0.79 MAOB (0.52) MAOBMAOASIK1SIK2SIK3
SCHEMBL10762758 0.79 SIK1 (0.60) MAOBMAOASIK1SIK2SIK3
SCHEMBL26259504 0.78 MAPK13 (0.46) PDGFRBPDGFRANPC1RAB9ACYP1A1
SCHEMBL26260086 0.78 PDGFRB (0.44) PDGFRBPDGFRANPC1TUBB4ATUBB
SCHEMBL26259484 0.78 KDM4E (0.51) NPC1RAB9ACYP1A1CYP1A2CYP2E1
SCHEMBL26260037 0.74 CYP11B1 (0.53) ERN1CYP1A1CYP1A2CYP2E1CYP3A4
SCHEMBL26260061 0.74 KDM4E (0.57) NPC1RAB9ACYP1A1CYP1A2CYP3A4
SCHEMBL26260002 0.73 F2 (0.44) NPC1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL26260006 0.73 KMT2A (0.37) NPC1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL5991829 0.72 MAOB (0.52) MAOBMAOASIK1SIK2SIK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 — — US disclosed
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND NUDC, CCNL2, SPIN3 MAOB 549/4885MAOA 513/4885SIK1 99/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback